Filing Flows › Idexx Laboratories (IDXX) › Q1 2025
Idexx Laboratories (IDXX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
Idexx Laboratories (IDXX) reported revenue of $998M for the first quarter 2025 (Q1 2025), +4% from a year earlier and +5% from the quarter before. Operating margin was 31.7%, net earnings $243M (24.3% of revenue).
Idexx Laboratories, Q1 2025: revenue $998M (+4% year over year), operating margin 31.7%, net earnings $243M, operating cash flow $238M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $998M | +5% | +4% |
| Gross profit | $623M | +9% | +5% |
| Operating profit | $317M | +21% | +6% |
| Net earnings | $243M | +12% | +3% |
| Operating cash flow | $238M | -9% | +20% |
| Free cash flow | $208M | -11% | +24% |
What changed
Revenue was $998.4M in Q1 2025, up 4% year over year and up 5% from the previous quarter. Product revenue was the largest line at 57% of revenue. Product revenue added $30.0M year over year (up 6%), 87% of the total change.
Gross margin was 62.4%, up 0.9 points from a year earlier. Operating profit was $316.5M, a 31.7% margin (up 0.7 points year over year). Of the extra revenue versus a year earlier, 51% reached operating profit, above the 31% margin then. Operating expenses grew 4% against revenue growth of 4%. The fastest-growing cost line was Research & development (+12%). Net earnings were $242.7M, up 3% year over year. The effective tax rate was 21.7%.
Operating cash flow was $238.0M (up 20% year over year), 98% of net earnings. Non-cash charges added back $34.1M of depreciation and amortization and $14.6M of share-based compensation. Working capital and other items used $53.4M. Capital expenditures of $30.0M left free cash flow of $207.9M.
Questions
What was Idexx Laboratories' revenue in the first quarter 2025?
Idexx Laboratories (IDXX) reported revenue of $998M for the first quarter 2025 (Q1 2025), +4% from a year earlier and +5% from the quarter before.
Was Idexx Laboratories profitable in the first quarter 2025?
Operating profit was $317M (31.7% of revenue) and net earnings $243M.
Source: Idexx Laboratories 10-Q on SEC EDGAR.